Latest Stock Split Details
Key information about Altamira Therapeutics Ltd.'s most recent stock split
Split Date: 2023-12-13
Split Ratio: 1:20
Price Before Split: $0.23
Price After Split: $0.01
Developer API
Get CYTO split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/CYTO
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 20.00 times fewer shares (a 1:20 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Altamira Therapeutics Ltd.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2023-12-13 | 1:20 | Yes | $0.23 | $0.01 |
| 2022-10-25 | 1:20 | Yes | $0.42 | $0.02 |
| 2019-05-01 | 1:20 | Yes | $0.22 | $0.01 |
| 2018-03-14 | 1:10 | Yes | $0.17 | $0.02 |
About Altamira Therapeutics Ltd.
Company overview and industry information
Altamira Therapeutics Ltd. (CYTO) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Altamira Therapeutics Ltd. Summary